by S. Nass, H. Moses
Publisher: National Academies Press 2007
Number of pages: 252
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition.
Home page url
Download or read it online for free here:
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by William H. Ward, Jeffrey M. Farma (eds) - Codon Publications
The book provides an overview of the epidemiology, pathology, and evidence-based treatment options for patients with all stages of melanoma. These aspects are presented in two sections: epidemiology and pathophysiology, and therapy and management.
by Ke Xu (ed.) - InTech
Metastasis is the major cause of cancer-related death. The mechanism underlying metastasis is complicated and poorly understood. Recent advances in tumor metastasis research have led to improved diagnosis and clinical management of cancer.
- National Academies Press
In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance ...